About this document
PP-21034 V2 - VONJO Distribution and Access Leave Behind - Digital - FINAL - 10.2.24 by kingcrawdk64 is a document available to read on EtoBox.
VONJO® (pacritinib) is a medication approved for use in the United States and Puerto Rico, available in 100 mg capsules, with a recommended dosage of 200 mg twice daily. VONJO Connect™ offers patient support, including insurance evaluation, financial assistance programs, and access to specialty pharmacies. Patients can enroll in various assistance programs to help cover costs and navigate insurance requirements.
- Author
- kingcrawdk64
- Language
- EN